Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 3
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all
Page 1
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming.
Kowalik MA, Puliga E, Cabras L, Sulas P, Petrelli A, Perra A, Ledda-Columbano GM, Morandi A, Merlin S, Orrù C, Sanchez-Martin C, Fornari F, Gramantieri L, Parri M, Rasola A, Bellomo SE, Sebastian C, Follenzi A, Giordano S, Columbano A. Kowalik MA, et al. Among authors: orru c. J Hepatol. 2020 Jun;72(6):1159-1169. doi: 10.1016/j.jhep.2019.12.018. Epub 2020 Jan 15. J Hepatol. 2020. PMID: 31954205
Nrf2 in Neoplastic and Non-Neoplastic Liver Diseases.
Orrù C, Giordano S, Columbano A. Orrù C, et al. Cancers (Basel). 2020 Oct 12;12(10):2932. doi: 10.3390/cancers12102932. Cancers (Basel). 2020. PMID: 33053665 Free PMC article. Review.
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis.
Orrù C, Perra A, Kowalik MA, Rizzolio S, Puliga E, Cabras L, Giordano S, Columbano A. Orrù C, et al. Cancers (Basel). 2020 Aug 16;12(8):2305. doi: 10.3390/cancers12082305. Cancers (Basel). 2020. PMID: 32824383 Free PMC article.
Genetic inactivation of Nrf2 prevents clonal expansion of initiated cells in a nutritional model of rat hepatocarcinogenesis.
Orrù C, Szydlowska M, Taguchi K, Zavattari P, Perra A, Yamamoto M, Columbano A. Orrù C, et al. J Hepatol. 2018 Sep;69(3):635-643. doi: 10.1016/j.jhep.2018.05.010. Epub 2018 Jun 22. J Hepatol. 2018. PMID: 29758334